Edwards Lifesciences
Update in progressEW (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Edwards Lifesciences provides products and technologies to treat advanced cardiovascular diseases worldwide. It offers transcatheter aortic valve replacement with the Edwards SAPIEN family, and transcatheter repair and replacement for mitral and tricuspid disease with PASCAL and EVOQUE. It also markets surgical structural heart solutions, including INSPIRIS RESILIA and related valve technologies (KONECT RESILIA, MITRIS RESILIA), and aortic valves. Distributed through direct sales and distributors; based in Irvine, California.
Company score
- Sentiment
- -0.31
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.23
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.59
- Governance
- -1.39
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.18
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!